Global /China /Healthcare /Biotechnology /688278

Xiamen Amoytop Biotech Co., Ltd.

688278

• SSE: 688278 • Delayed

58.25CNY -1.9%

8.61 USD

As of 16 June 2026, Xiamen Amoytop Biotech Co., Ltd. has a market cap of $3.58B USD, ranking #4816 globally and #1008 in China. It ranks #370 in the Healthcare sector, and #65 in the Biotechnology industry.

Global Rank

4816

Country Rank

1008

Sector Rank

370

Industry Rank

Key Stats

Market Cap

$3.58BUSD

24.23B CNY

Enterprise Value

$3.45BUSD

23.33B CNY

Revenue (TTM)

$564.14MUSD

3.82B CNY

EBITDA (TTM)

$194.85MUSD

1.32B CNY

Net Income (TTM)

$149.69MUSD

1.01B CNY

EBITDA Margin

35%

Profit Margin

27%

PE Ratio

24.1

Forward PE

19.0

PS Ratio

6.3

PB Ratio

6.7

EV/EBITDA

17.6

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Biotechnology

CEO

Li Sun open_in_new

Employees

3,644

Founded

1996

Website

amoytop.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-1.9%	-5.6%	-15%	-24%	-20%	-31%	-24%	27%	72%

News

Markets

Exchange	Ticker	Price	Quotes
Shanghai Stock Exchange (SSE / SHA) MIC: XSHG PRIMARY	688278 厦门特宝生物工程股份有限公司 Class A ISIN: CNE100003RT3 Shares Out.: Shares Outstanding: 408.189M¹ Shares Float: 168.365M² TV: TradingView: SSE: 688278 SA: Stock Analysis: SHA: 688278 YF: Yahoo Finance: 688278.SS GF: Google Finance: SHA: 688278 BA: Barron's: 688278 MS: Morningstar: XSHG: 688278	58.25 CNY	TV: TradingView: SSE: 688278 SA: Stock Analysis: SHA: 688278 YF: Yahoo Finance: 688278.SS GF: Google Finance: SHA: 688278 BA: Barron's: 688278 MS: Morningstar: XSHG: 688278

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Xiamen Amoytop Biotech Co., Ltd.

Xiamen Amoytop Biotech Co., Ltd. engages in research, development, production, and sale of recombinant protein drugs in China and internationally. It offers various drug products, including pegsomatropin injection, pegfilgrastim injection, molgramostim, filgrastim, and oprelvekin; active pharmaceutical ingredients (APIs); and reagents to treat viral hepatitis, malignant tumors, and immunotherapy. Xiamen Amoytop Biotech Co., Ltd. was founded in 1996 and is headquartered in Xiamen, China.

Similar Companies

Industry: Biotechnology (China)

Name	Market Cap (USD) diff.	PE	Country
WuXi Biologics (Cayman) Inc. SHEK: 2269	$17.45B 136.71B HKD 388%	25.3	China
CSPC Pharmaceutical Group Ltd. SHEK: 1093	$12.2B 95.58B HKD 241%	22.1	China
Sichuan Kelun Pharmaceutical Co., Ltd. SHE: 002422	$8.01B 54.23B CNY 124%	34.4	China
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. SSE: 603392	$7.34B 49.69B CNY 105%	-	China
3SBio Inc. SHEK: 1530	$7.08B 55.5B HKD 98%	5.8	China
Hangzhou Tigermed Consulting Co., Ltd. SHE: 300347	$6.72B 45.52B CNY 88%	61.6	China

Industry: Biotechnology (Global)

Name	Market Cap (USD) diff.	PE	Country
Amgen Inc. NASDAQ: AMGN	$182.42B 5K%	23.9	United States
Gilead Sciences, Inc. NASDAQ: GILD	$159.92B 4K%	19.0	United States
argenx SE EBR: ARGX	$47.99B 41.39B EUR 1K%	39.9	Netherlands
Samsung Biologics Co.,Ltd. KRX: 207940	$45.02B 68.19T KRW 1K%	35.5	South Korea
CSL Ltd. ASX: CSL	$42.64B 60.27B AUD 1K%	29.3	Australia
Lonza Group AG SIX: LONN	$42.46B 33.71B CHF 1K%	37.2	Switzerland

chevron_leftBack